Skip to main content

The Role of the Navigator During a Patient’s Cancer Treatment

  • Chapter
  • First Online:
Team-Based Oncology Care: The Pivotal Role of Oncology Navigation

Abstract

The purpose of this chapter is to provide an overview of the most common types of cancer treatment modalities and to describe the role of navigators on the multidisciplinary treatment team during these phases of care. Patients may receive just one phase of treatment, such as surgery, or may be transitioned through various phases of treatment such as surgery, chemotherapy, radiation, and hormonal therapy. Each phase or treatment requires decision-making, and the navigator serves as a patient advocate and patient educator and promotes the patient’s active participation in the treatment decisions that are being made. Navigators also reassess the patient for any barriers to care; these barriers can change depending on the phase of treatment the patient is receiving at any given time. A description of multi-level barriers, and strategies to address those barriers, is provided. Tables are provided for ease of reference. Several case studies are presented to highlight the role of the navigator throughout treatment. Special attention is given to Native American cancer patients, as well as sexual and gender minorities, two populations often ignored in mainstream patient navigation literature.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 64.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 69.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Willis LA, Reed E, Pratt-Chapman M, Kapp H, Hatcher E, Vaitones V, Collins S, Bires J, Washington E. Development of a framework for patient navigation: delineating roles across navigator types. J Oncol Navig Surviv. 2013;4:20–6.

    Google Scholar 

  2. Morra M, Potts E. Choices. New York: Avon Books; 1994.

    Google Scholar 

  3. www.NatAmCancer.org.

  4. http://natamcancer.org/page80.html.

  5. www.cancer.org/content/cancer/en/treatment/treatments-and-side-effects/treatment-types/radiation/basics.html.

  6. www.cancer.org/content/cancer/en/search.html?q=targeted+therapies.

  7. www.cancer.gov/about-cancer/treatment/types/targeted-therapies/targeted-therapies-fact-sheet.

  8. www.merckmanuals.com/home/hormonal-and-metabolic-disorders/biology-of-the-endocrine-system/endocrine-function.

  9. www.cancer.gov/about-cancer/treatment/types/hormone-therapy.

  10. www.webmd.com/women/rm-quiz-secret-life-of-hormones.

  11. www.cancer.gov/about-cancer/treatment/types/hormone-therapy#HTCCSE.

  12. www.cancer.org/treatment/treatments-and-side-effects/treatment-types/immunotherapy/what-is-immunotherapy.html.

  13. www.cancer.gov/about-cancer/treatment/types/immunotherapy.

  14. National Cancer Institute. Immunotherapy. 2017. www.cancer.gov/research/areas/treatment/immunotherapy-using-immune-system.

  15. National Cancer Institute. Immunotherapy. 2017. www.cancer.gov/about-cancer/treatment/types/immunotherapy.

  16. www.cancer.org/treatment/treatments-and-side-effects/treatment-types/stem-cell-transplant/transplant-side-effects.html.

  17. http://natamcancer.org/page51.html.

  18. http://natamcancer.org/page49.html.

  19. www.webmd.com/diet/features/cancer-supplements#1.

  20. Parkinson AJ, Gold BD, Bulkow L, Wainwright RB, Swaminathan B, Khanna B, Peterson KM, Fitzgerald MA. High prevalence of Helicobacter pylori in the Alaska Native Population and Association with low serum ferritin levels in young adults. Clin Diagn Lab Immunol. 2000;7(6):885–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Linda Burhansstipanov MSPH, DrPH .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Burhansstipanov, L., Shockney, L.D. (2018). The Role of the Navigator During a Patient’s Cancer Treatment. In: Shockney, L. (eds) Team-Based Oncology Care: The Pivotal Role of Oncology Navigation. Springer, Cham. https://doi.org/10.1007/978-3-319-69038-4_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-69038-4_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-69037-7

  • Online ISBN: 978-3-319-69038-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics